Pelle Life Sciences-Emerging (6949): February 2026 Revenue Reaches 0.02 Hundred Million (+61.2% YoY)

Pelle Life Sciences-Emerging (6949) has announced its financial report for February 2026. The company's revenue for the month was 1,971 thousand (0.02 hundred million), a 61.2% increase compared to the same month last year. Pelle Life Sciences-Emerging is a company specializing in the biotechnology and healthcare industry.
生技醫療業NQ 55/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: February 1, 2026 at 09:00
  • 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
  • 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Stock Code: 6949
Company Name: Pelle Life Sciences-Emerging
Industry: Biotechnology & Healthcare
Data for Month: 2026-02
Revenue for the Month: 1,971 thousand (0.02 hundred million)
Year-on-Year Change: +61.2%

FAQ

What was Pelle Life Sciences-Emerging's revenue for February 2026?

Pelle Life Sciences-Emerging's revenue for February 2026 reached 1,971 thousand, which is equivalent to 0.02 hundred million.

How much did Pelle Life Sciences-Emerging's revenue grow year-on-year in February 2026?

Pelle Life Sciences-Emerging's revenue experienced a significant year-on-year growth of +61.2% in February 2026.

What is the stock code for Pelle Life Sciences-Emerging?

The stock code for Pelle Life Sciences-Emerging is 6949.

In which industry does Pelle Life Sciences-Emerging operate?

Pelle Life Sciences-Emerging operates within the Biotechnology & Healthcare industry.

What was the specific revenue figure reported for February 2026 by Pelle Life Sciences-Emerging?

The specific revenue figure reported for February 2026 by Pelle Life Sciences-Emerging was 1,971 thousand.